Clinical trial
Phase 2 Study of Metabolic Syndrome Use Omega-3 Fatty Acids and Low Fat Meal Replacements
NCT01768169 is registered in ClinicalTrials.gov with Taipei Medical University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2 Study of Metabolic Syndrome Use Omega-3 Fatty Acids and Low Fat Meal Replacements
- Lead sponsor
- Taipei Medical University Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 30, 2012
- Completion date
- July 31, 2013
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.